Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

NCT00828308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ixabepilone
PROCEDURE: Prostatectomy

Sponsor

Brown University

Collaborators

[object Object]
[object Object]